86126-8

86126-8 is a code from the Logical Observation Identifiers Names and Codes (LOINC) system, which is used worldwide to standardize medical terminology for electronic health data exchange. The specific LOINC code 86126-8 refers to a laboratory test panel for detecting the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, and other similar viruses. This panel may include tests like nucleic acid amplification tests (NAATs), including PCR (Polymerase Chain Reaction), which are designed to identify genetic material from the virus in respiratory samples. The purpose of using this LOINC code is to ensure that test results and data are uniformly recorded and interpreted, facilitating better communication and data sharing among healthcare providers, laboratories, and researchers. This is crucial for tracking public health trends, managing patient care, and conducting research on the virus and related illnesses.

The 86126-8 chip is not a widely recognized part number for standard components. It might be a custom or proprietary part, often specific to certain equipment or manufacturer. To find an equivalent, you should identify its function, specifications, and manufacturer, then look for chips with similar features from manufacturers like Texas Instruments, Microchip, Analog Devices, or others. Check datasheets and consult with suppliers or engineers for alternatives matching the specific requirements.

The LOINC code 86126-8 corresponds to a laboratory test for "Amphetamines [Presence] in Umbilical cord by Screen method." This test is used to detect the presence of amphetamines in the umbilical cord tissue, which can provide information about maternal drug use during pregnancy. The screening method employed is typically an initial qualitative analysis to identify whether amphetamines are present, indicating potential exposure of the fetus to these substances. This test can be a part of newborn drug screening protocols, particularly in cases where drug use is suspected, to help assess the need for further confirmatory testing or medical interventions. It assists healthcare providers in making informed decisions about the care and management of both the newborn and the mother.

The part number 86126-8 is associated with Delphi Automotive, which is now known as Aptiv PLC. Aptiv is a global technology company that focuses on developing safer, greener, and more connected solutions for the automotive sector. They provide a wide range of components and solutions, including electrical and electronic systems, active safety systems, and user experience technologies. Aptiv aims to enhance vehicle functionality, connectivity, and safety, supporting the evolution of autonomous and electric vehicles.

LOINC code 86126-8 refers to the "Influenza virus A M gene [Presence] in Respiratory specimen by NAA with probe detection." This test is used in medical diagnostics to detect the presence of Influenza A virus in respiratory specimens. It employs nucleic acid amplification (NAA) with probe detection, making it a sensitive and specific method for identifying viral genetic material. Application areas include diagnosing influenza infections in patients presenting with symptoms, monitoring outbreaks, and guiding treatment decisions, particularly during flu seasons or pandemics. It is essential for public health surveillance and controlling the spread of influenza.